Sanofi earns orphan drug designation from USFDA for multiple myeloma drug Ruchika Sharma30 July 2025 1:30 PM ISTParis: Sanofi has received orphan drug designation from the US Food and Drug Administration (FDA) for SAR446523, an IgG1-based...
Fatty Liver Index Predicts Hepatocellular Carcinoma Risk in T2DM Without Cirrhosis: Study Dr Riya Dave30 July 2025 9:00 AM ISTA new study has established that the follow-up of the fatty liver index (FLI), both baseline and longitudinally, is an effective predictor of the risk...
3 Out of 5 Liver Cancer Cases Preventable, Says Lancet Commission; Calls for Urgent Focus on Hepatitis, Alcohol, and Obesity Dr. Bhumika Maikhuri30 July 2025 8:00 AM ISTA new report from The Lancet Commission reveals that over 60% of liver cancer cases globally could be prevented by addressing modifiable risk factors...
Medical Bulletin 29/July/2025 Dr. Bhumika Maikhuri29 July 2025 3:00 PM ISTHere are the top medical news for the day:After How Long Is Dementia Usually Diagnosed?A new systematic review and meta-analysis published in the...
AstraZeneca Imfinzi gets USFDA priority review for resectable early stage gastric, gastroesophageal junction cancers Ruchika Sharma29 July 2025 1:30 PM ISTCambridge: AstraZeneca has announced that the company's supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab) has...
Bayer Sevabertinib accepted for review in China for advanced non-small cell lung cancer Ruchika Sharma29 July 2025 11:30 AM ISTBerlin: Bayer has announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has accepted for...
This Sugar Substitute May Help Kill Cancer Cells: Study Suggests Dr. Bhumika Maikhuri29 July 2025 8:15 AM ISTIn a new study, researchers from Hiroshima University have found that stevia, commonly known as a zero-calorie sweetener, may possess potent...
Polygenic Risk Score Outperforms PSA and MRI in Detecting Clinically Significant Prostate Cancer: NEJM Dr Riya Dave28 July 2025 8:15 PM ISTResearchers have found in a new BARCODE1 study that a polygenic risk score identified a higher proportion of clinically significant prostate cancer...
Understanding how a key protein helps aggressive blood cancer grow, paving the way for targeted therapies: Study Dr. Kamal Kant Kohli27 July 2025 9:15 PM ISTAcute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment...
Temozolomide and radiation treatment tied to Dramatic Tumor Regression and Hearing Restoration in Adult Brainstem Glioma: Study with a rare IDH2 mutation Dr. Kamal Kant Kohli27 July 2025 9:00 PM ISTA group led by the Department of Neurosurgery at the Brain Research Institute, Niigata University, has successfully treated a patient with a brainstem...
Robotic surgery for rectal cancer after preoperative neo-adjuvant CRT improves outcomes: Study Jacinthlyn Sylvia27 July 2025 8:30 PM ISTA new study published in the journal of BMC Surgery showed that robotic surgery for rectal cancer exhibits oncological and technical safety results...
GSK Blenrep combos approved in EU for treatment of relapsed/refractory multiple myeloma Ruchika Sharma27 July 2025 11:00 AM ISTLondon: GSK plc has received approval for Blenrep in the European Union (EU) for the treatment of adults with relapsed or refractory...
